Fate Therapeutics
FATE
#8490
Rank
C$0.40 B
Marketcap
C$3.51
Share price
-7.35%
Change (1 day)
171.70%
Change (1 year)

Market capitalization of Fate Therapeutics (FATE)

Market cap: C$0.40 Billion

As of August 2026 Fate Therapeutics has a market cap of C$0.40 Billion. This makes Fate Therapeutics the world's 8490th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fate Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.40 B159.15%
2025C$0.15 B-39.96%
2024C$0.26 B-46.2%
2023C$0.48 B-63.24%
2022C$1.33 B-81.32%
2021C$7.12 B-29.6%
2020C$10.11 B422.58%
2019C$1.93 B71.2%
2018C$1.13 B179.61%
2017C$0.40 B189.66%
2016C$0.13 B3.99%
2015C$0.13 B11.81%
2014C$0.12 B-12.1%
2013C$0.13 B

End of Day market cap according to different sources

On Aug 12th, 2026 the market cap of Fate Therapeutics was reported to be:

C$0.44 Billion
by Nasdaq info icon info icon
C$0.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Becton Dickinson
BDX
C$69.08 B 16,774.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$2.71 B 562.40%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$8.37 B 1,944.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$21.36 B 5,119.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$15.67 B 3,729.77%๐Ÿ‡บ๐Ÿ‡ธ USA